Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Lung Cancer Diagnosis and Therapeutics Revenue 1.4 Market Analysis by Type 1.4.1 Global Lung Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Non-Small Cell Lung Cancer 1.4.3 Small Cell Lung Cancer 1.5 Market by Application 1.5.1 Global Lung Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Cancer Research Centers 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends by Regions 2.1 Lung Cancer Diagnosis and Therapeutics Market Perspective (2015-2026) 2.2 Lung Cancer Diagnosis and Therapeutics Growth Trends by Regions 2.2.1 Lung Cancer Diagnosis and Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Lung Cancer Diagnosis and Therapeutics Historic Market Share by Regions (2015-2020) 2.2.3 Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Lung Cancer Diagnosis and Therapeutics Market Growth Strategy 2.3.6 Primary Interviews with Key Lung Cancer Diagnosis and Therapeutics Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Lung Cancer Diagnosis and Therapeutics Players by Market Size 3.1.1 Global Top Lung Cancer Diagnosis and Therapeutics Players by Revenue (2015-2020) 3.1.2 Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Players (2015-2020) 3.1.3 Global Lung Cancer Diagnosis and Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Lung Cancer Diagnosis and Therapeutics Market Concentration Ratio 3.2.1 Global Lung Cancer Diagnosis and Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Lung Cancer Diagnosis and Therapeutics Revenue in 2019 3.3 Lung Cancer Diagnosis and Therapeutics Key Players Head office and Area Served 3.4 Key Players Lung Cancer Diagnosis and Therapeutics Product Solution and Service 3.5 Date of Enter into Lung Cancer Diagnosis and Therapeutics Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Lung Cancer Diagnosis and Therapeutics Historic Market Size by Type (2015-2020) 4.2 Global Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Type (2021-2026) 5 Lung Cancer Diagnosis and Therapeutics Breakdown Data by Application (2015-2026) 5.1 Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 5.2 Global Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 6.2 Lung Cancer Diagnosis and Therapeutics Key Players in North America (2019-2020) 6.3 North America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 6.4 North America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 7 Europe 7.1 Europe Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 7.2 Lung Cancer Diagnosis and Therapeutics Key Players in Europe (2019-2020) 7.3 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 7.4 Europe Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 8 China 8.1 China Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 8.2 Lung Cancer Diagnosis and Therapeutics Key Players in China (2019-2020) 8.3 China Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 8.4 China Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 9 Japan 9.1 Japan Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 9.2 Lung Cancer Diagnosis and Therapeutics Key Players in Japan (2019-2020) 9.3 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 9.4 Japan Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 10.2 Lung Cancer Diagnosis and Therapeutics Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 10.4 Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 11 India 11.1 India Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 11.2 Lung Cancer Diagnosis and Therapeutics Key Players in India (2019-2020) 11.3 India Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 11.4 India Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size (2015-2020) 12.2 Lung Cancer Diagnosis and Therapeutics Key Players in Central & South America (2019-2020) 12.3 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) 12.4 Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 AstraZeneca 13.1.1 AstraZeneca Company Details 13.1.2 AstraZeneca Business Overview and Its Total Revenue 13.1.3 AstraZeneca Lung Cancer Diagnosis and Therapeutics Introduction 13.1.4 AstraZeneca Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020)) 13.1.5 AstraZeneca Recent Development 13.2 Eli Lilly 13.2.1 Eli Lilly Company Details 13.2.2 Eli Lilly Business Overview and Its Total Revenue 13.2.3 Eli Lilly Lung Cancer Diagnosis and Therapeutics Introduction 13.2.4 Eli Lilly Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.2.5 Eli Lilly Recent Development 13.3 Sanofi 13.3.1 Sanofi Company Details 13.3.2 Sanofi Business Overview and Its Total Revenue 13.3.3 Sanofi Lung Cancer Diagnosis and Therapeutics Introduction 13.3.4 Sanofi Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.3.5 Sanofi Recent Development 13.4 ArQule 13.4.1 ArQule Company Details 13.4.2 ArQule Business Overview and Its Total Revenue 13.4.3 ArQule Lung Cancer Diagnosis and Therapeutics Introduction 13.4.4 ArQule Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.4.5 ArQule Recent Development 13.5 Daiichi Sankyo 13.5.1 Daiichi Sankyo Company Details 13.5.2 Daiichi Sankyo Business Overview and Its Total Revenue 13.5.3 Daiichi Sankyo Lung Cancer Diagnosis and Therapeutics Introduction 13.5.4 Daiichi Sankyo Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.5.5 Daiichi Sankyo Recent Development 13.6 Celgene 13.6.1 Celgene Company Details 13.6.2 Celgene Business Overview and Its Total Revenue 13.6.3 Celgene Lung Cancer Diagnosis and Therapeutics Introduction 13.6.4 Celgene Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.6.5 Celgene Recent Development 13.7 Merck 13.7.1 Merck Company Details 13.7.2 Merck Business Overview and Its Total Revenue 13.7.3 Merck Lung Cancer Diagnosis and Therapeutics Introduction 13.7.4 Merck Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.7.5 Merck Recent Development 13.8 Pfizer 13.8.1 Pfizer Company Details 13.8.2 Pfizer Business Overview and Its Total Revenue 13.8.3 Pfizer Lung Cancer Diagnosis and Therapeutics Introduction 13.8.4 Pfizer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.8.5 Pfizer Recent Development 13.9 Boehringer Ingelheim 13.9.1 Boehringer Ingelheim Company Details 13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue 13.9.3 Boehringer Ingelheim Lung Cancer Diagnosis and Therapeutics Introduction 13.9.4 Boehringer Ingelheim Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.9.5 Boehringer Ingelheim Recent Development 13.10 Roche 13.10.1 Roche Company Details 13.10.2 Roche Business Overview and Its Total Revenue 13.10.3 Roche Lung Cancer Diagnosis and Therapeutics Introduction 13.10.4 Roche Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 13.10.5 Roche Recent Development 13.11 Genentech 10.11.1 Genentech Company Details 10.11.2 Genentech Business Overview and Its Total Revenue 10.11.3 Genentech Lung Cancer Diagnosis and Therapeutics Introduction 10.11.4 Genentech Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.11.5 Genentech Recent Development 13.12 GSK 10.12.1 GSK Company Details 10.12.2 GSK Business Overview and Its Total Revenue 10.12.3 GSK Lung Cancer Diagnosis and Therapeutics Introduction 10.12.4 GSK Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.12.5 GSK Recent Development 13.13 Pharmacyclics 10.13.1 Pharmacyclics Company Details 10.13.2 Pharmacyclics Business Overview and Its Total Revenue 10.13.3 Pharmacyclics Lung Cancer Diagnosis and Therapeutics Introduction 10.13.4 Pharmacyclics Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.13.5 Pharmacyclics Recent Development 13.14 Novartis 10.14.1 Novartis Company Details 10.14.2 Novartis Business Overview and Its Total Revenue 10.14.3 Novartis Lung Cancer Diagnosis and Therapeutics Introduction 10.14.4 Novartis Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.14.5 Novartis Recent Development 13.15 Bayer 10.15.1 Bayer Company Details 10.15.2 Bayer Business Overview and Its Total Revenue 10.15.3 Bayer Lung Cancer Diagnosis and Therapeutics Introduction 10.15.4 Bayer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.15.5 Bayer Recent Development 13.16 Bristol-Myers Squibb 10.16.1 Bristol-Myers Squibb Company Details 10.16.2 Bristol-Myers Squibb Business Overview and Its Total Revenue 10.16.3 Bristol-Myers Squibb Lung Cancer Diagnosis and Therapeutics Introduction 10.16.4 Bristol-Myers Squibb Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.16.5 Bristol-Myers Squibb Recent Development 13.17 Eisai 10.17.1 Eisai Company Details 10.17.2 Eisai Business Overview and Its Total Revenue 10.17.3 Eisai Lung Cancer Diagnosis and Therapeutics Introduction 10.17.4 Eisai Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.17.5 Eisai Recent Development 13.18 AbbVie 10.18.1 AbbVie Company Details 10.18.2 AbbVie Business Overview and Its Total Revenue 10.18.3 AbbVie Lung Cancer Diagnosis and Therapeutics Introduction 10.18.4 AbbVie Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) 10.18.5 AbbVie Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

List of Tables Table 1. Lung Cancer Diagnosis and Therapeutics Key Market Segments Table 2. Key Players Covered: Ranking by Lung Cancer Diagnosis and Therapeutics Revenue Table 3. Ranking of Global Top Lung Cancer Diagnosis and Therapeutics Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Lung Cancer Diagnosis and Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Non-Small Cell Lung Cancer Table 6. Key Players of Small Cell Lung Cancer Table 7. Global Lung Cancer Diagnosis and Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 8. Global Lung Cancer Diagnosis and Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026 Table 9. Global Lung Cancer Diagnosis and Therapeutics Market Size by Regions (2015-2020) (US$ Million) Table 10. Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions (2015-2020) Table 11. Global Lung Cancer Diagnosis and Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 12. Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026) Table 13. Market Top Trends Table 14. Key Drivers: Impact Analysis Table 15. Key Challenges Table 16. Lung Cancer Diagnosis and Therapeutics Market Growth Strategy Table 17. Main Points Interviewed from Key Lung Cancer Diagnosis and Therapeutics Players Table 18. Global Lung Cancer Diagnosis and Therapeutics Revenue by Players (2015-2020) (Million US$) Table 19. Global Lung Cancer Diagnosis and Therapeutics Market Share by Players (2015-2020) Table 20. Global Top Lung Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnosis and Therapeutics as of 2019) Table 21. Global Lung Cancer Diagnosis and Therapeutics by Players Market Concentration Ratio (CR5 and HHI) Table 22. Key Players Headquarters and Area Served Table 23. Key Players Lung Cancer Diagnosis and Therapeutics Product Solution and Service Table 24. Date of Enter into Lung Cancer Diagnosis and Therapeutics Market Table 25. Mergers & Acquisitions, Expansion Plans Table 26. Global Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 27. Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Type (2015-2020) Table 28. Global Lung Cancer Diagnosis and Therapeutics Revenue Market Share by Type (2021-2026) Table 29. Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Application (2015-2020) Table 30. Global Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 31. Global Lung Cancer Diagnosis and Therapeutics Market Size Share by Application (2021-2026) Table 32. North America Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 33. North America Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 34. North America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 35. North America Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 36. North America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 37. North America Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 38. Europe Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 39. Europe Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 40. Europe Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 41. Europe Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 42. Europe Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 43. Europe Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 44. China Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 45. China Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 46. China Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 47. China Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 48. China Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 49. China Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 50. Japan Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 51. Japan Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 52. Japan Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 53. Japan Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 54. Japan Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 55. Japan Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 56. Southeast Asia Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 57. Southeast Asia Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 58. Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 59. Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 60. Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 61. Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 62. India Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 63. India Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 64. India Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 65. India Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 66. India Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 67. India Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 68. Central & South America Key Players Lung Cancer Diagnosis and Therapeutics Revenue (2019-2020) (Million US$) Table 69. Central & South America Key Players Lung Cancer Diagnosis and Therapeutics Market Share (2019-2020) Table 70. Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Type (2015-2020) (Million US$) Table 71. Central & South America Lung Cancer Diagnosis and Therapeutics Market Share by Type (2015-2020) Table 72. Central & South America Lung Cancer Diagnosis and Therapeutics Market Size by Application (2015-2020) (Million US$) Table 73. Central & South America Lung Cancer Diagnosis and Therapeutics Market Share by Application (2015-2020) Table 74. AstraZeneca Company Details Table 75. AstraZeneca Business Overview Table 76. AstraZeneca Product Table 77. AstraZeneca Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 78. AstraZeneca Recent Development Table 79. Eli Lilly Company Details Table 80. Eli Lilly Business Overview Table 81. Eli Lilly Product Table 82. Eli Lilly Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 83. Eli Lilly Recent Development Table 84. Sanofi Company Details Table 85. Sanofi Business Overview Table 86. Sanofi Product Table 87. Sanofi Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 88. Sanofi Recent Development Table 89. ArQule Company Details Table 90. ArQule Business Overview Table 91. ArQule Product Table 92. ArQule Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 93. ArQule Recent Development Table 94. Daiichi Sankyo Company Details Table 95. Daiichi Sankyo Business Overview Table 96. Daiichi Sankyo Product Table 97. Daiichi Sankyo Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 98. Daiichi Sankyo Recent Development Table 99. Celgene Company Details Table 100. Celgene Business Overview Table 101. Celgene Product Table 102. Celgene Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 103. Celgene Recent Development Table 104. Merck Company Details Table 105. Merck Business Overview Table 106. Merck Product Table 107. Merck Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 108. Merck Recent Development Table 109. Pfizer Business Overview Table 110. Pfizer Product Table 111. Pfizer Company Details Table 112. Pfizer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 113. Pfizer Recent Development Table 114. Boehringer Ingelheim Company Details Table 115. Boehringer Ingelheim Business Overview Table 116. Boehringer Ingelheim Product Table 117. Boehringer Ingelheim Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 118. Boehringer Ingelheim Recent Development Table 119. Roche Company Details Table 120. Roche Business Overview Table 121. Roche Product Table 122. Roche Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 123. Roche Recent Development Table 124. Genentech Company Details Table 125. Genentech Business Overview Table 126. Genentech Product Table 127. Genentech Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 128. Genentech Recent Development Table 129. GSK Company Details Table 130. GSK Business Overview Table 131. GSK Product Table 132. GSK Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 133. GSK Recent Development Table 134. Pharmacyclics Company Details Table 135. Pharmacyclics Business Overview Table 136. Pharmacyclics Product Table 137. Pharmacyclics Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 138. Pharmacyclics Recent Development Table 139. Novartis Company Details Table 140. Novartis Business Overview Table 141. Novartis Product Table 142. Novartis Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 143. Novartis Recent Development Table 144. Bayer Company Details Table 145. Bayer Business Overview Table 146. Bayer Product Table 147. Bayer Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 148. Bayer Recent Development Table 149. Bristol-Myers Squibb Company Details Table 150. Bristol-Myers Squibb Business Overview Table 151. Bristol-Myers Squibb Product Table 152. Bristol-Myers Squibb Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 153. Bristol-Myers Squibb Recent Development Table 154. Eisai Company Details Table 155. Eisai Business Overview Table 156. Eisai Product Table 157. Eisai Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 158. Eisai Recent Development Table 159. AbbVie Company Details Table 160. AbbVie Business Overview Table 161. AbbVie Product Table 162. AbbVie Revenue in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) (Million US$) Table 163. AbbVie Recent Development Table 164. Research Programs/Design for This Report Table 165. Key Data Information from Secondary Sources Table 166. Key Data Information from Primary Sources List of Figures Figure 1. Global Lung Cancer Diagnosis and Therapeutics Market Share by Type: 2020 VS 2026 Figure 2. Non-Small Cell Lung Cancer Features Figure 3. Small Cell Lung Cancer Features Figure 4. Global Lung Cancer Diagnosis and Therapeutics Market Share by Application: 2020 VS 2026 Figure 5. Hospitals Case Studies Figure 6. Cancer Research Centers Case Studies Figure 7. Lung Cancer Diagnosis and Therapeutics Report Years Considered Figure 8. Global Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth 2015-2026 (US$ Million) Figure 9. Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions: 2020 VS 2026 Figure 10. Global Lung Cancer Diagnosis and Therapeutics Market Share by Regions (2021-2026) Figure 11. Porter's Five Forces Analysis Figure 12. Global Lung Cancer Diagnosis and Therapeutics Market Share by Players in 2019 Figure 13. Global Top Lung Cancer Diagnosis and Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Lung Cancer Diagnosis and Therapeutics as of 2019 Figure 14. The Top 10 and 5 Players Market Share by Lung Cancer Diagnosis and Therapeutics Revenue in 2019 Figure 15. North America Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 16. Europe Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 17. China Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Japan Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Southeast Asia Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 20. India Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 21. Central & South America Lung Cancer Diagnosis and Therapeutics Market Size YoY Growth (2015-2020) (Million US$) Figure 22. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. AstraZeneca Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 24. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. Eli Lilly Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 26. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. Sanofi Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 28. ArQule Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. ArQule Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 30. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Daiichi Sankyo Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 32. Celgene Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Celgene Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 34. Merck Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. Merck Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 36. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Pfizer Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 38. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018 Figure 39. Boehringer Ingelheim Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 40. Roche Total Revenue (US$ Million): 2019 Compared with 2018 Figure 41. Roche Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 42. Genentech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 43. Genentech Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 44. GSK Total Revenue (US$ Million): 2019 Compared with 2018 Figure 45. GSK Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 46. Pharmacyclics Total Revenue (US$ Million): 2019 Compared with 2018 Figure 47. Pharmacyclics Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 48. Novartis Total Revenue (US$ Million): 2019 Compared with 2018 Figure 49. Novartis Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 50. Bayer Total Revenue (US$ Million): 2019 Compared with 2018 Figure 51. Bayer Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 52. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018 Figure 53. Bristol-Myers Squibb Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 54. Eisai Total Revenue (US$ Million): 2019 Compared with 2018 Figure 55. Eisai Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 56. AbbVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 57. AbbVie Revenue Growth Rate in Lung Cancer Diagnosis and Therapeutics Business (2015-2020) Figure 58. Bottom-up and Top-down Approaches for This Report Figure 59. Data Triangulation Figure 60. Key Executives Interviewed

AstraZeneca Eli Lilly Sanofi ArQule Daiichi Sankyo Celgene Merck Pfizer Boehringer Ingelheim Roche Genentech GSK Pharmacyclics Novartis Bayer Bristol-Myers Squibb Eisai AbbVie